DNA testing of colorectal polyps improves insight into hereditary risks

For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.
Targeted Oncology

Blood-Based Colorectal Cancer Test Shows High Sensitivity in APLs

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting

Rhythm Biosciences Ltd ('RHY', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated ...
Frontiers

Current Trends in Clinical Management of Colorectal Cancer

Colorectal cancer (CRC) remains one of the most prevalent and lethal malignancies worldwide, representing a major challenge ...

Researchers find new approach to Opdivo-resistant colorectal cancer

KYOTO--Researchers at Kyoto University have identified a new approach to a type of colorectal cancer that is resistant to ...
European Medical Journal

Psychiatric Disorders Linked to Colorectal Cancer Risk

New UK Biobank data link psychiatric disorders with higher colorectal cancer risk. Learn more about the screening and ...

Rhythm Biosciences enhances geneType colorectal cancer test with clinical and lifestyle risk factors

Rhythm Biosciences has materially improved the predictive accuracy of its geneType colorectal cancer risk assessment clinical ...